A new medium for the isolation of Pseudomonas cepacia from respiratory tract secretions of patients with cystic fibrosis (CF) is described. This medium consists of inorganic salts, 0.5% pyruvate, and 0.1% proteose peptone as nutritive components and 0.0001% crystal violet, 0.15% bile salts, 100 ,ug of ticarcillin per ml, and 300 U of polymyxin B per ml as selective agents. The medium, designated PC medium, supported superior growth of 38 of 50 stock isolates of P. cepacia after 48 h of incubation when compared with MacConkey agar
Recent studies have suggested that Pseudomonas cepacia may be emerging as an important pulmonary pathogen in patients with cystic fibrosis (CF) (6, 8, 12) . In a casecontrolled study, CF patients colonized with P. cepacia were more frequently hospitalized and died earlier than control CF patients (O. C. Tablan, T Carson , W. J. Martone, J. M. Jason, and W. R. Jarvis, J. Pediatr., in press). Clinical experience suggests that the emergence of this organism in the respiratory tree of older CF patients can be associated with rapid deterioration in pulmonary status and death (6) . Despite these data, the role of P. cepacia in pulmonary disease of CF patients remains unclear. One of the major problems in determining the actual incidence of colonization by P. cepacia in CF patients with severe pulmonary disease has been difficulty in isolating this organism. Although P. cepacia can survive and multiply in hostile environments such as distilled water and disinfectants (2) (3) (4) , it has been our experience that it often grows more slowly on commonly used laboratory media such as blood and MacConkey agar than do other organisms, such as Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli commonly found in the respiratory tree of CF patients. We have also observed that P. cepacia can be overgrown by these organisms on media commonly used for its isolation. We designed an isolation medium for the recovery Table 2 ) used Six P. cepacia strains were chosen at random for the comparison of quantitative recovery of this organism on PC medium, MacConkey agar, and 5% sheep blood agar. These strains were grown overnight in Trypticase soy broth and diluted 1:10,000 in saline to make a stock suspension. This stock suspension was diluted 1:10, 1:100, and 1:1,000 in saline, and 0.1 ml of the stock suspension and each dilution was plated onto duplicate plates of each medium. After 48 h of incubation at 35°C, each plate was counted, and the number of organisms for each strain recovered on each type of medium was recorded.
Culture of clinical specimens. Respiratory secretions, primarily sputa, deep pharyngeal swabs, and bronchial washings, were cultured from patients identified by physicians or by patient registry at two CF centers as having CF. At SCHC, the cultures were made with PC medium, 5% sheep blood agar, chocolate agar, mannitol salt agar (Difco), and MacConkey agar. Cultures at North Carolina Memorial Hospital were made on the same media as at SCHC, except that 5% horse blood agar and colistin-nalixidic acid agar were substituted for chocolate agar and sheep blood agar. All plates were incubated at 35°C for 72 h and examined daily for the presence of P. cepacia and other potential respiratory pathogens. P. cepacia was identified by the following criteria: colonial morphology, disk diffusion susceptibility testing, and (at SCHC) the Uni-N/F Tek (Flow Laboratories, Inc., McLean, Va.) or (at North Carolina Memorial Hospital) conventional biochemical testing (5) . All other potential pathogens were identified by standard techniques (9) .
RESULTS
Preliminary studies. Studies were done to modify the holding medium formulation of DeCicco to develop an isolation medium for the recovery of P. cepacia. Certain additions to the medium were found to be necessary. An amino acid source (0.1% proteose peptone no. 3) was required for the growth of some of the P. cepacia isolates. Experiments were also done to examine different selective agents. The addition of 0. 15% bile salts and either 100 or 300 U of polymyxin B per ml allowed similar growth of 10 P. cepacia isolates when compared with media without these components. Because of this observation, 10 clinical specimens from CF patients were cultured on the holding medium containing 0.1% proteose peptone no. 3, 0.15% bile salts, and 300 U of polymyxin B per ml to assess its selectivity. These experiments showed that S. aureus, mucoid and rough strains of P. aeruginosa, Proteus mirabilis, yeast, and mold, as well as P. cepacia, grew on this medium. Because of these findings, 100 p.g of ticarcillin per ml and 0.0001% crystal violet were added to the medium, the former to inhibit gram-negative organisms and the latter to inhibit gram-positive organisms.
Growth and selectivity studies. Experiments were performed which compared the growth of 50 clinical isolates of P. cepacia on MacConkey and 5% sheep blood agar and on PC medium, which contained 300 U of polymyxin B per ml, 100 ,ug of ticarcillin per ml, 0.15% bile salts, and 0.0001% crystal violet. Growth on PC medium was equal or superior to growth on MacConkey agar after 48 h of incubation (Table  1) . Comparative growth on 5% sheep blood agar and PC medium showed that most isolates (84%) grew equally well on the two media. In addition, all 50 P. cepacia isolates grew on PC medium within 48 h.
Quantitative studies to compare the recovery of six P. cepacia strains on these three media were performed by quantitatively culturing a 1:10,000 dilution of an overnight broth culture of these strains. Sheep blood was the most sensitive, with an average recovery for these six strains of 1.2 x 104 CFU/ml. PC medium was nearly as sensitive, with an average recovery of 9.1 x 103 CFU/ml, and MacConkey agar was the least sensitive, with an average recovery of 6.1 x 103 CFU/ml.
To assess the selective nature of this medium, 120 isolates of various gram-negative bacilli and 4 isolates of S. aureus were examined for their ability to grow on PC medium ( Table 2 ). The choice of gram-negative bacilli for study was based on the likelihood of recovery from sputa of CF patients (1) . None of the four strains of S. aureus grew on this medium. Of 120 gram-negative bacillus isolates, 12 grew on PC medium, and all grew on MacConkey agar. Of the organisms tested, strains of Klebsiella pneumoniae were able to grow most frequently on PC medium. All 12 non-P. cepacia isolates which grew on PC medium did poorly when compared with their growth on MacConkey agar. Because of the ability of PC medium to support the growth of all P. cepacia isolates tested and its ability to inhibit the growth of over 90% of isolates likely to be encountered in respiratory secretions of CF patients, PC medium was examined to determine whether it could be used as a primary isolation medium to enhance the recovery of P. cepacia from respiratory cultures from CF patients.
Clinical studies. Respiratory secretions from 169 CF patients at two CF centers were examined for the presence of potential respiratory tract pathogens, with special emphasis on the detection of P. cepacia. P. cepacia was present in CF patients at both centers ( Table 3 ). The recovery rate at center 1 (27%) was significantly higher than that at center 2 (2%). The recovery of S. aureus (48 and 47%, respectively) and P. aeruginosa (58 and 72%, respectively) at the two centers, on the other hand, was similar.
When recovery of P. cepacia on PC medium was compared with that on MacConkey agar, PC medium was clearly superior (Table 4) . Of the 35 isolates of P. cepacia recovered, 14 were found only on PC medium. This was, in part, because in cultures from seven patients there was confluent growth of highly mucoid strains of P. aeruginosa on MacConkey agar which probably obscured or inhibited the growth of P. cepacia. In isolates from 18 patients, the growth of P. cepacia was superior on PC medium; three isolates showed similar growth on the two media. No isolates were found only on MacConkey agar, nor did any isolate grow better on MacConkey agar.
The ability of PC medium to inhibit the growth of other potential pathogens was also examined. Of 221 potential pathogens, only 6 grew on PC medium (Table 5) . These included two ticarcillin-resistant P. aeruginosa isolates, two mold isolates, an isolate of Serratia sp., and one yeast. No organisms which would be considered normal respiratory flora, such as diphtheroids, saprophytic Neisseria sp., coagulase-negative staphylococci, and oral streptococci, grew on PC medium (data not shown).
Description of the growth of P. cepacia on PC medium. PC medium is dull yellow when uninoculated. After 24 h of grown on PC medium, P. cepacia colonies are usually (6, 8, 12) . One characteristic of P. cepacia which has made its emergence particularly distressing has been its resistance, in vitro and in vivo, to both conventional and experimental antimicrobial therapy (7). The role of P. cepacia in pulmonary disease remains controversial. In cases in which it is recognized, the spectrum of disease can range from long-term colonization to rapidly progressive (1 to 3 weeks) fatal illness. Unlike P. aeruginosa, P. cepacia is relatively avirulent in animal models (4, 11) . Although isolates from CF patients have both proteolytic and lipolytic activities, they produce neither elastase nor toxins similar to P. aeruginosa toxin A, both of which are postulated to be important virulence factors in pulmonary disease in CF patients (10; P. H. Gilligan To assess the role of P. cepacia in pulmonary disease of CF patients, an isolation medium specific for it appears to be essential. P. cepacia has been reported to be present in as few as 1% to as many as 27% of CF patients, depending on the reporting center (1). These may represent real differ-VOL. 22, 1985 on July 1, 2017 by guest http://jcm.asm.org/ Downloaded from ences in the centers, as was shown in this study (with a selective medium, 27% of the patients were positive for P. cepacia in one center and 2% in the other), or differences in the ability of different laboratories to recognize P. cepacia among flora growing in isolates from the respiratory tract of CF patients. A major concern when clinical specimens from CF patients are examined for P. cepacia is its slow growth on commonly used laboratory media when compared with other organisms present in these specimens. Mucoid strains of P. aeruginosa are of particular concern, as shown in this study: 20% of the P. cepacia isolates were not recovered on MacConkey agar in the presence of heavy growth of mucoid strains ofP. aeruginosa. These isolates would not have been detected by means other than PC medium. Overall, 40% of the P. cepacia strains isolated in this study were found only on PC medium. These data suggest that a selective medium specific for P. cepacia isolation, such as PC medium, should be used to obtain more accurate epidemiological information concerning the role that P. cepacia plays in the pulmonary deterioration seen in CF patients.
Two other selective media for the isolation of P. cepacia have recently been described. One medium (M. J. Muszynski, D. A. Pickett, and D. F. Welch, Program Abstr. 24th Intersci. Conf. Antimicrob. Agents Chemother., abstr. no. 179, 1984) , in which bacitracin and polymyxin B are used as selective agents, and production of acid from lactose is used as a differential test, has been shown to support the growth of stock cultures of P. cepacia, which has been recovered on this medium from sputa seeded with it. With this medium, P. cepacia was not recovered from sputum specimens obtained from 25 CF patients (D. Welch, personal communication).
The other medium that was recently described (14) was designed to recover P. cepacia from environmental sources. With 9-chlora-9-(4-diethylaminophenyl)-10-phenylacridan and polymyxin B as selective agents, it effectively inhibits the growth of most organisms. However, Serratia marcescens and P. cepacia grow equally well on this medium. In addition, the efficacy of recovery of P. cepacia is judged by using only environmental water specimens. It would be difficult to extrapolate the utility of this medium for isolation of P. cepacia from clinical specimens based on studies with environmental water specimens.
The use of PC medium should enhance the recovery of P. cepacia from respiratory secretions of CF patients. The more reliable recovery of P. cepacia from CF patients should aid in the evaluation of the role of this organism in pulmonary disease in CF patients.
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